Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
Maturitas(3)
Área temáticas
Farmacología y terapéutica(2)
Enfermedades(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Salud y seguridad personal(1)
Origen
scopus(3)
EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture
ArticleAbstract: Introduction Osteoporotic vertebral fractures are associated with significant morbidity, excess mortPalabras claves:Conservative treatment, diagnosis, OSTEOPOROSIS, Surgical treatment, Vertebral fractureAutores:Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Lambropoulou-Adamidou K., Nacopoulos C.C., Papaioannou N.A., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., Triantafyllopoulos I.K., van der Schouw Y.T.Fuentes:scopusEMAS position statement: The ten point guide to the integral management of menopausal health
ArticleAbstract: With increased longevity and more women becoming centenarians, management of the menopause and postrPalabras claves:Hot Flushes, menopausal hormone therapy, MENOPAUSE, OSTEOPOROSIS, Postreproductive health, screeningAutores:Birkhauser M., Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Llaneza P., Neves-E-Castro M., Palacios S., Rees M., Samsioe G., Sánchez-Borrego R., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopusOsteoporosis management in patients with breast cancer: EMAS position statement
ReviewAbstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrogPalabras claves:adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screeningAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopus